Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC

2014 ◽  
Vol 11 (1) ◽  
pp. 4-14 ◽  
Author(s):  
Michael Michael ◽  
Shane C White ◽  
Ehtesham Abdi ◽  
Louise Nott ◽  
Phillip Clingan ◽  
...  
Keyword(s):  
Phase Ii ◽  
Advanced Nsclc ◽  
Phase Ii Trial ◽  
First Line ◽  
Open Label ◽  
First Line Therapy ◽  
Line Therapy ◽  
Open Label Phase ◽  
Ecog Ps

scholarly journals An Open‐Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX‐6 as First‐Line Therapy for Metastatic Colorectal Cancer

2014 ◽  
Vol 19 (4) ◽  
pp. 350-351 ◽  
Author(s):  
Rocio Garcia‐Carbonero ◽  
Fernando Rivera ◽  
Joan Maurel ◽  
Jean‐Pierre M. Ayoub ◽  
Malcolm J. Moore ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Open Label ◽  
Safety And Efficacy ◽  
First Line Therapy ◽  
Line Therapy ◽  
Open Label Phase

scholarly journals Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

2011 ◽  
Vol 105 (3) ◽  
pp. 353-359 ◽  
Author(s):  
T Eisen ◽  
R Marais ◽  
A Affolter ◽  
P Lorigan ◽  
C Robert ◽  
...  
Keyword(s):  
Phase I ◽  
Phase Ii ◽  
Advanced Melanoma ◽  
First Line ◽  
Open Label ◽  
First Line Therapy ◽  
Line Therapy ◽  
Phase Ii Studies ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document